Skip to main content

Table 3 Comparison of adverse reactions between the two groups (n, %)

From: Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis

Indicator

Etanercept group (n = 33)

Adalimumab group (n = 33)

χ2

P

Significant difference in normal distribution (P)

erythema

1

1

   

pruritus

2

2

   

pain

0

0

   

swell

1

2

   

Total adverse reaction rate (%)

4

5

0.129

0.719

0.092

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us